Keiichi Enjyoji Selected Research

Keiichi Enjyoji Research Topics

Disease

11	Inflammation (Inflammations) 01/2021 - 04/2002
10	Thrombosis (Thrombus) 01/2021 - 04/2002
6	Vascular System Injuries 01/2020 - 03/2004
5	Neoplasms (Cancer) 01/2022 - 10/2007
3	Colitis 11/2018 - 09/2009
2	Fibrosis (Cirrhosis) 01/2019 - 01/2008
2	Crohn Disease (Crohn's Disease) 11/2018 - 05/2011
2	Hypoxia (Hypoxemia) 11/2018 - 09/2003
2	Atherosclerosis 01/2017 - 12/2002
2	Reperfusion Injury 12/2011 - 03/2004
2	Vascular Remodeling 06/2009 - 12/2002
2	Pathologic Constriction (Stenosis) 06/2009 - 12/2002
2	Hyperplasia 06/2009 - 12/2002
2	Ischemia 03/2006 - 03/2004
2	Vascular Diseases (Vascular Disease) 03/2006 - 04/2005
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	COVID-19 01/2022
1	Hemorrhage 01/2020
1	Sepsis (Septicemia) 01/2015
1	Dehydration (Water Stress) 08/2012
1	Thrombocytopenia (Thrombopenia) 08/2012
1	Cytokine Release Syndrome 12/2011
1	Lung Injury 12/2011
1	Neoplasm Metastasis (Metastasis) 06/2011
1	Experimental Melanoma 09/2010
1	Colonic Neoplasms (Colon Cancer) 09/2010
1	Liver Diseases (Liver Disease) 09/2008
1	Glucose Intolerance 09/2008
1	Insulin Resistance 09/2008
1	Hepatitis 09/2008
1	Pancreatitis 01/2008
1	Pancreatic Diseases (Pancreatic Disease) 01/2008
1	Sclerosis 09/2007
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2007

Drug/Important Bio-Agent (IBA)

11	NucleotidesIBA 01/2021 - 04/2002
7	Adenosine Triphosphate (ATP)IBA 01/2022 - 04/2002
5	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 09/2003
4	triphosphoric acid (triphosphate)IBA 01/2021 - 04/2002
4	NucleosidesIBA 09/2010 - 04/2002
3	Purinergic Receptors (Receptors, Purine)IBA 01/2021 - 10/2007
3	Messenger RNA (mRNA)IBA 06/2011 - 09/2003
2	CollagenIBA 01/2019 - 01/2008
2	CholesterolIBA 01/2017 - 12/2002
2	Apyrase (ATP Diphosphatase)IBA 01/2015 - 03/2004
2	SodiumIBA 01/2015 - 05/2011
2	Adenosine Diphosphate (ADP)IBA 12/2014 - 04/2002
2	Proteins (Proteins, Gene)FDA Link 06/2011 - 01/2008
2	Dextrans (Dextran)FDA Link 05/2011 - 09/2009
2	Phenobarbital (Luminal)FDA Link 06/2009 - 12/2002
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 06/2009 - 12/2002
2	Liposomes (Liposome)IBA 06/2009 - 12/2002
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Diphosphates (Pyrophosphates)IBA 01/2021
1	SaltsIBA 01/2020
1	ZincIBA 01/2020
1	Factor XII (Hageman Factor)IBA 01/2020
1	Edetic Acid (EDTA)FDA Link 01/2020
1	CalciumIBA 01/2020
1	Chelating AgentsIBA 01/2020
1	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 01/2019
1	Dextran SulfateIBA 11/2018
1	XenobioticsIBA 11/2018
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2018
1	LigandsIBA 11/2018
1	BilirubinIBA 11/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 11/2018
1	Ritonavir (Norvir)FDA Link 11/2018
1	Therapeutic UsesIBA 11/2018
1	purineIBA 01/2013
1	Thrombin FDA Link 08/2012
1	Sulfonic AcidsIBA 05/2011
1	OxazoloneIBA 05/2011
1	HaptensIBA 05/2011
1	LuciferasesIBA 09/2010
1	Transaminases (Aminotransferases)IBA 05/2010
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 09/2009
1	Phosphotransferases (Kinase)IBA 09/2008
1	Concanavalin AIBA 09/2008
1	Protein Kinases (Protein Kinase)IBA 09/2008
1	Insulin (Novolin)FDA Link 09/2008
1	CytokinesIBA 01/2008
1	RNA (Ribonucleic Acid)IBA 01/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2008
1	CeruletideIBA 01/2008
1	IntegrinsIBA 10/2007

Therapy/Procedure

3	Therapeutics 01/2022 - 09/2010
3	Transplantation 01/2008 - 04/2005
2	Ligation 11/2018 - 01/2015
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Lasers (Laser) 01/2020
1	Punctures 01/2015
1	Heterologous Transplantation (Xenotransplantation) 08/2012
1	Liver Transplantation 08/2012
1	Euthanasia (Mercy Killing) 12/2011
1	Intraperitoneal Injections 01/2008
1	Injections 01/2008